Dr. Marc J. Kahn

Request as Speaker

Request as Media Expert

Chief of Hematology, Department of Internal Medicine

Expertise: Medicine, Hematology, Oncology, Health education, Business of medicine

Biography

Dr. Marc J. Kahn is chief of hematology at the Kirk Kerkorian School of Medicine's Department of Internal Medicine. He is a prolific researcher in benign hematology, medical education, and healthcare finance.

He has served in leadership roles with the Association of American Medical Colleges, American College of Physicians, American Society of Hematology, National Board of Medical Examiners, and the National Residency Matching Program.

Dr. Kahn has authored over 100 peer-reviewed manuscripts in addition to 110 book chapters and five textbooks. In 2020, his most recent textbook, “Business Basics of Building and Managing a Healthcare Practice,” was published by Springer Nature.

He formerly served as vice president for health affairs at UNLV and as dean of the university's medical school — developing curricula, clinical programs, and research to elevate healthcare in the region. Prior to joining UNLV in April 2020, Dr. Kahn was a senior associate dean at Tulane University School of Medicine.

Education

M.D., University of Pennsylvania School of Medicine
M.B.A., Tulane University
B.A., Chemistry, University of Pennsylvania

Search For Other Experts On

health & medicine

Dr. Marc J. Kahn In The News

UNLV doctor details sunscreen significance of FDA approving new UV-blocking ingredient

The Food and Drug Administration has approved a new sunscreen active ingredient for use in over-the-counter products, marking the first time in roughly 20 years that Americans will have access to a new formula.

UNLV doctor explains breakthrough as experimental pill gives hope for cancer treatment

Research shows that a novel pill helped people with advanced pancreatic cancer live longer, raising hopes of long-needed better treatments for one of the deadliest types of cancer. The drug is called daraxonrasib and it blocks a mutated protein that fuels tumor growth in more than 90% of pancreatic cancer cases — a target that had eluded treatment for decades.

UNLV expert outlines West Nile virus symptoms and bite-prevention steps for residents

Southern Nevada is seeing its first reported case of West Nile virus this season, with Clark County confirming an infection in a local resident.

Groundbreaking Drug May Double Survival Time for Pancreatic Cancer

Everyday Health

Results from a late-stage clinical trial of the pill daraxonrasib offer new hope for a notoriously deadly disease, doctors say.